27th Annual Liver Disease Wrap-Up
utilize the latest developments in the diagnosis, staging, and treatment of metabolic-associated steatotic liver disease (MASLD), identify new developments in the diagnosis and treatment of cholestatic, autoimmune, and genetic liver diseases, implement new treatments including the use of immunotherapies for hepatocellular carcinoma.